In a very significant move the TGA has approved Hospira's INFLECTRA across eight inflammatory conditions, extrapolating data from two Phase 3 clinical trials in rheumatoid arthritis and ankylosing spondylitis. …
Latest Video
New Stories
-
'We are very unhappy that we were not consulted as it is an expectation'
December 3, 2024 - - Latest News -
Albanese Government launches review of Australia’s research and development
December 2, 2024 - - Latest News -
Brisbane health-tech unveils advanced manufacturing facility
December 2, 2024 - - Latest News -
Pharmac minister celebrates increase in access to medicines following budget boost
December 2, 2024 - - Latest News -
Orthocell says it has achieved all endpoints in pivotal of nerve repair product
December 2, 2024 - - Australian Biotech -
AusBiotech welcomes experienced industry executive to its board
December 2, 2024 - - Latest News -
4DMedical signs contract to expand in Western Australia
December 2, 2024 - - Australian Biotech